Health Team
Duke brain tumor vaccine
Duke University researchers have had promising results in clinical trials from a monthly vaccine for people with brain cancer. The vaccine targets genetic mutations in the tumors in about one-third of patients.
Duke University researchers have had promising results in clinical trials from a monthly vaccine for people with brain cancer. The vaccine targets genetic mutations in the tumors in about one-third of patients.